
Olomorasib (KRAS G12C ингибитор 19, LY3537982) is a мощный and highly селективный second-generation ингибитор of GDP-bound KRAS G12C, with the potential to treat patients with advanced solid tumors carrying the KRAS G12C mutation.
Olomorasib (KRAS G12C inhibitor 19, LY3537982) is a potent and highly selective second-generation inhibitor of GDP-bound KRAS G12C, with the potential to treat patients with advanced solid tumors carrying the KRAS G12C mutation.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.